Medicine and Dentistry
Cryptococcal Meningitis
63%
Human Immunodeficiency Virus
50%
Cerebrospinal Fluid
28%
Antiretroviral Therapy
26%
Mortality
21%
Meningitis
19%
Diagnosis
17%
Patient
15%
Adult
14%
Culture
12%
Combination Therapy
11%
Cells
10%
Antigen
10%
Immune Reconstitution Inflammatory Syndrome
10%
Person
10%
Symptom
8%
Analysis
8%
Tuberculous Meningitis
8%
Clinical Trial
8%
Inpatient
7%
Therapeutic Procedure
7%
Association
6%
Blood
6%
Infection
5%
Intracranial Pressure
5%
Amphotericin
5%
Lumbar Puncture
5%
Health
5%
Serum
5%
Survival
5%
Immunology and Microbiology
Meningitis
100%
Human Immunodeficiency Virus
61%
Cerebrospinal Fluid
37%
Antigen
28%
Mortality
26%
Tuberculous Meningitis
12%
Flow
11%
Cells
10%
Immune Reconstitution Inflammatory Syndrome
9%
Coinfection
9%
Survival
8%
Sample
6%
Blood Plasma
6%
CD4 Lymphocyte Count
6%
Filobasidiella
6%
Liquid
5%
Cytomegalovirus
5%
Cryptococcus neoformans
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cryptococcal Meningitis
50%
HIV
45%
Meningitis
21%
Fluconazole
18%
Amphotericin
14%
Amphotericin B
12%
Sertraline
10%
Tuberculous Meningitis
10%
Mortality
9%
Amphotericin B Deoxycholate
7%
Survival
7%
Filobasidiella
6%
Antigen
6%
Tuberculosis
6%
Adverse Event
5%
Prevalence
5%
Cryptococcus neoformans
5%
Mixed Infection
5%
Cryptococcosis
5%
Drug
5%
Pharmacokinetics
5%